Close Menu

NEW YORK – Researchers have begun enrolling patients in an adaptive clinical trial aimed at uncovering new treatments for glioblastoma.

There has been little change in recent decades in treatment options for glioblastoma or in patient outcomes. About half of the patients diagnosed with glioblastoma die within the first 15 months of being diagnosed and 95 percent die within five years of being diagnosed. 

Get the full story with
Premium Access

Only $95 for the
first 90 days*

Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try Premium Access now.

You may already have institutional access!

Check if I qualify.

Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.